Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

2012 Surveillance Slides

Surveillance Slides Previous Slide Next Slide Last Slide
Slide 31. Completion of TB Therapy, United States, 1993–2010.

Slide 31. Completion of TB Therapy, United States, 1993–2010. The reporting areas began providing information on completion of therapy in 1993 through the individual TB case report form. The calculations exclude persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or positive blood culture. Overall completion of therapy had remained at approximately 92-93% from 1998 through 2008, but increased to 95% in 2009. Completion in 1 year or less increased from 64% in 1993 to 88% in 2010, the latest year with available data. The current DHHS Healthy People 2020 objective is completion of therapy in 1 year or less in 93% of patients. CDC is working with state and local health departments to determine and evaluate reasons for apparently delayed completion of therapy, which may vary by jurisdiction.

Back to 2012 Surveillance Slides Main Page